Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Fentanyl Sandoz
Fentanyl 2.1mg
Transdermal patch
Novartis New Zealand Limited
Hexal AG, Holzkirchen, Germany
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Fentanyl Sandoz
Fentanyl 4.2mg
Transdermal patch
Novartis New Zealand Limited
Hexal AG, Holzkirchen, Germany
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Fentanyl Sandoz
Fentanyl 6.3mg
Transdermal patch
Novartis New Zealand Limited
Hexal AG, Holzkirchen, Germany
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Fentanyl Sandoz
Fentanyl 8.4mg
Transdermal patch
Novartis New Zealand Limited
Hexal AG, Holzkirchen, Germany
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Fentanyl Sandoz
Fentanyl 12.6mg
Transdermal patch
Novartis New Zealand Limited
Hexal AG, Holzkirchen, Germany
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Fentanyl Sandoz
Fentanyl 16.8mg
Transdermal patch
Novartis New Zealand Limited
Hexal AG, Holzkirchen, Germany
|
Dated this 8th day of January 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz